Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Seditol
- Development stage
- Unknown
- Lead developer
- Lonza
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Seditol is a proprietary nutraceutical ingredient composed of a patented blend of *Magnolia officinalis* (magnolia bark) and *Ziziphus jujuba* (jujube seed) extracts. It is designed to support relaxation and improve sleep quality by calming an overactive mind and reducing stress-related arousal. The mechanism of action involves the synergistic interaction of its botanical constituents—such as honokiol and magnolol from magnolia—with the central nervous system, specifically through the modulation of GABA-A and adenosine receptors. Developed by InterHealth Nutraceuticals (now a part of Lonza), Seditol is widely used as a key component in various over-the-counter dietary supplements aimed at managing sleep disorders and promoting nighttime rest without the grogginess associated with pharmaceutical sedatives.
- Brand names
- Seditol
02
Targets
GABRA2 (Gamma-aminobutyric acid receptor subunit alpha 2)ADOR (Adenosine receptors)
Beyond the preview
Go deeper on Seditol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Seditol.